Related Experiment Videos
Nephrolithiasis and intestinal disease.
Journal of Clinical Gastroenterology
|February 1, 1985
Summary
Patients with inflammatory bowel disease often develop calcium oxalate kidney stones due to increased oxalate absorption. This abstract details a therapeutic approach to correct the underlying physiological abnormalities contributing to stone formation.
Area of Science:
- Nephrology
- Gastroenterology
- Urology
Background:
- Inflammatory bowel disease (IBD) is associated with an increased risk of kidney stone formation.
- Calcium oxalate stones are the predominant type in IBD patients.
- Key factors include increased intestinal oxalate absorption and colonic permeability.
Purpose of the Study:
- To elucidate the mechanisms behind increased oxalate absorption in IBD patients.
- To identify contributing factors to calcium oxalate nephrolithiasis in this population.
- To outline a therapeutic strategy for managing kidney stones in IBD.
Main Methods:
- Review of physiological mechanisms of oxalate absorption in the gastrointestinal tract.
- Analysis of factors influencing colonic permeability to oxalate.
- Description of a clinical therapeutic approach.
Main Results:
- Steatorrhea in IBD contributes to enhanced oxalate absorption.
- Increased colonic permeability exacerbates oxalate absorption.
- Physiological abnormalities can be therapeutically addressed.
Conclusions:
- Understanding oxalate absorption pathways is crucial for managing kidney stones in IBD.
- Targeting steatorrhea and colonic permeability offers therapeutic potential.
- A structured therapeutic approach can mitigate calcium oxalate stone formation in IBD patients.